NutriBand (NTRB) Shareholder's Equity Growth (5y) (2021 - 2026)
NutriBand (NTRB) Shareholder's Equity Growth (5y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
| 10 |
NutriBand |
39.29 Mn |
34.71 Mn |
196,801.00 |
| Date | Value |
|---|
| Apr 30, 2026 |
-5.23% |
| Jan 31, 2026 |
-1.25% |
| Oct 31, 2025 |
0.80% |
| Jul 31, 2025 |
45.63% |
| Apr 30, 2025 |
28.22% |
| Jan 31, 2025 |
105.50% |
| Oct 31, 2024 |
59.94% |
| Jul 31, 2024 |
50.14% |
| Apr 30, 2024 |
45.02% |
| Jan 31, 2024 |
21.77% |
| Oct 31, 2023 |
18.73% |
| Jul 31, 2023 |
18.82% |
| Apr 30, 2023 |
175.85% |
| Jan 31, 2023 |
134.26% |
| Oct 31, 2022 |
32.50% |
| Jul 31, 2022 |
33.10% |
| Apr 30, 2022 |
288.15% |
| Jan 31, 2022 |
248.38% |
| Oct 31, 2021 |
245.44% |
| Jul 31, 2021 |
586.16% |
